Research and Markets: The Neurotechnology Industry 2013 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/pwwz3l/the) has announced the addition of NeuroInsights's new report "The Neurotechnology Industry 2013 Report" to their offering.

Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets

Now in its ninth year, The Neurotechnology Industry 2013 Report is an expanded and updated 600 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 18 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, traumatic brain injury and stroke.

Report Highlights

The Neurotechnology Industry 2013 Report provides a unified market-based framework to help executives, investors, and governments easily identify opportunities, understand the competitive landscape and visualize the dynamics of these rapidly growing markets.

Key Topics Covered:

1: Executive Summary

2: Trends and Drivers

Read the rest here:
Research and Markets: The Neurotechnology Industry 2013 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics ...